Shopping Cart 0
Cart Subtotal
USD 0

Medicago Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Medicago Inc (Medicago), a subsidiary of Mitsubishi Tanabe Pharma Corp is a clinical-stage biotechnology company that develops and produces vaccines and antibodies. The company concentrates on the discovery and development of novel vaccines and therapeutic proteins for infectious diseases. Its pipeline products includes pandemic flu vaccine and seasonal flu vaccines. Medicago's seasonal flu vaccine is used for contagious respiratory illness. The company also develops H1N1 pandemic candidate vaccines; and rabies, rotavirus and biosimilar vaccination. It uses its technologies including plant-based proficia technology, virus-like particles and the VLPExpress platform for the development of vaccines. The company conducts research activities in the areas of biodefence and biosimilar therapies. It operates in North Carolina, and production facility in Canada. Medicago is headquartered in Quebec, Canada.

Medicago Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Medicago Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Medicago Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Medicago Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Medicago Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Medicago Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Medicago Inc, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Medicago Enters into Contract with Public Health Agency of Canada 10

Medicago Enters into Agreement with University of Cape Town 11

Medicago Enters Into Co-Development Agreement With A Global Pharma Company 12

Medicago Enters Into Co-Development Agreement With Mitsubishi Tanabe Pharma For Vaccines 13

Medicago Enters Into Co-Development Agreement With Cellectis 14

Licensing Agreements 15

Medicago Enters Into Licensing Agreement With Philip Morris Products For Influenza Vaccines 15

Philip Morris Products Enters Into Licensing Agreement With Medicago For Protein Development Technologies 16

Immune Design And Medicago Enter Into Licensing Agreement To Develop Influenza Vaccines 17

Equity Offering 18

Medicago Announces Private Placement Of Common Stock For USD 3.4 Million 18

Acquisition 19

Medicago Completes Divestment Of 53.9% Stake To Mitsubishi Tanabe Pharma For USD 172 Million In Going Private Transaction 19

Medicago Inc-Key Competitors 21

Medicago Inc-Key Employees 22

Medicago Inc-Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Recent Developments 24

Clinical Trials 24

Sep 27, 2017: Mitsubishi Tanabe Pharma: Notice of the Start of Phase 3 Clinical Study of VLP Seasonal Influenza Vaccine 24

Sep 26, 2017: Medicago Announces Phase 3 Study of VLP Quadrivalent Influenza Vaccine 25

Other Significant Developments 26

Sep 18, 2018: Medicago officially starts the construction of its site in Estimauville's Innovation Area 26

Appendix 27

Methodology 27

About GlobalData 27

Contact Us 27

Disclaimer 27


List Of Figure

List of Figures

Medicago Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Medicago Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Medicago Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Medicago Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Medicago Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Medicago Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Medicago Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Medicago Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Medicago Inc, Pharmaceuticals & Healthcare, Key Facts 2

Medicago Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Medicago Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Medicago Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Medicago Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Medicago Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Medicago Enters into Contract with Public Health Agency of Canada 10

Medicago Enters into Agreement with University of Cape Town 11

Medicago Enters Into Co-Development Agreement With A Global Pharma Company 12

Medicago Enters Into Co-Development Agreement With Mitsubishi Tanabe Pharma For Vaccines 13

Medicago Enters Into Co-Development Agreement With Cellectis 14

Medicago Enters Into Licensing Agreement With Philip Morris Products For Influenza Vaccines 15

Philip Morris Products Enters Into Licensing Agreement With Medicago For Protein Development Technologies 16

Immune Design And Medicago Enter Into Licensing Agreement To Develop Influenza Vaccines 17

Medicago Announces Private Placement Of Common Stock For USD 3.4 Million 18

Medicago Completes Divestment Of 53.9% Stake To Mitsubishi Tanabe Pharma For USD 172 Million In Going Private Transaction 19

Medicago Inc, Key Competitors 21

Medicago Inc, Key Employees 22

Medicago Inc, Other Locations 23

Medicago Inc, Subsidiaries 23

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Medicago Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Medicago Inc (Medicago), a subsidiary of Mitsubishi Tanabe Pharma Corp is a clinical-stage biotechnology company that develops and produces vaccines and antibodies. The company concentrates on the discovery and development of novel vaccines and therapeutic proteins for infectious diseases. Its pipeline products includes pandemic flu vaccine and seasonal flu vaccines. Medicago's seasonal flu vaccine is used for contagious respiratory illness. The company also develops H1N1 pandemic candidate vaccines; and rabies, rotavirus and biosimilar vaccination. It uses its technologies including plant-based proficia technology, virus-like particles and the VLPExpress platform for the development of vaccines. The company conducts research activities in the areas of biodefence and biosimilar therapies. It operates in North Carolina, and production facility in Canada. Medicago is headquartered in Quebec, Canada.

Medicago Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Medicago Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Medicago Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Medicago Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Medicago Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Medicago Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Medicago Inc, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Medicago Enters into Contract with Public Health Agency of Canada 10

Medicago Enters into Agreement with University of Cape Town 11

Medicago Enters Into Co-Development Agreement With A Global Pharma Company 12

Medicago Enters Into Co-Development Agreement With Mitsubishi Tanabe Pharma For Vaccines 13

Medicago Enters Into Co-Development Agreement With Cellectis 14

Licensing Agreements 15

Medicago Enters Into Licensing Agreement With Philip Morris Products For Influenza Vaccines 15

Philip Morris Products Enters Into Licensing Agreement With Medicago For Protein Development Technologies 16

Immune Design And Medicago Enter Into Licensing Agreement To Develop Influenza Vaccines 17

Equity Offering 18

Medicago Announces Private Placement Of Common Stock For USD 3.4 Million 18

Acquisition 19

Medicago Completes Divestment Of 53.9% Stake To Mitsubishi Tanabe Pharma For USD 172 Million In Going Private Transaction 19

Medicago Inc-Key Competitors 21

Medicago Inc-Key Employees 22

Medicago Inc-Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Recent Developments 24

Clinical Trials 24

Sep 27, 2017: Mitsubishi Tanabe Pharma: Notice of the Start of Phase 3 Clinical Study of VLP Seasonal Influenza Vaccine 24

Sep 26, 2017: Medicago Announces Phase 3 Study of VLP Quadrivalent Influenza Vaccine 25

Other Significant Developments 26

Sep 18, 2018: Medicago officially starts the construction of its site in Estimauville's Innovation Area 26

Appendix 27

Methodology 27

About GlobalData 27

Contact Us 27

Disclaimer 27


List Of Figure

List of Figures

Medicago Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Medicago Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Medicago Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Medicago Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Medicago Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Medicago Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Medicago Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Medicago Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Medicago Inc, Pharmaceuticals & Healthcare, Key Facts 2

Medicago Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Medicago Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Medicago Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Medicago Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Medicago Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Medicago Enters into Contract with Public Health Agency of Canada 10

Medicago Enters into Agreement with University of Cape Town 11

Medicago Enters Into Co-Development Agreement With A Global Pharma Company 12

Medicago Enters Into Co-Development Agreement With Mitsubishi Tanabe Pharma For Vaccines 13

Medicago Enters Into Co-Development Agreement With Cellectis 14

Medicago Enters Into Licensing Agreement With Philip Morris Products For Influenza Vaccines 15

Philip Morris Products Enters Into Licensing Agreement With Medicago For Protein Development Technologies 16

Immune Design And Medicago Enter Into Licensing Agreement To Develop Influenza Vaccines 17

Medicago Announces Private Placement Of Common Stock For USD 3.4 Million 18

Medicago Completes Divestment Of 53.9% Stake To Mitsubishi Tanabe Pharma For USD 172 Million In Going Private Transaction 19

Medicago Inc, Key Competitors 21

Medicago Inc, Key Employees 22

Medicago Inc, Other Locations 23

Medicago Inc, Subsidiaries 23

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Medicago Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.